Coston, Mc Isaac & Partners Bio N Tech Se Transaction History
Coston, Mc Isaac & Partners
- $298 Million
- Q3 2024
A detailed history of Coston, Mc Isaac & Partners transactions in Bio N Tech Se stock. As of the latest transaction made, Coston, Mc Isaac & Partners holds 20 shares of BNTX stock, worth $2,282. This represents 0.0% of its overall portfolio holdings.
Number of Shares
20
Previous 20
-0.0%
Holding current value
$2,282
Previous $1,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding BNTX
# of Institutions
357Shares Held
38.3MCall Options Held
2.45MPut Options Held
2.29M-
Baillie Gifford & CO8.31MShares$948 Million0.75% of portfolio
-
Primecap Management CO Pasadena, CA4.52MShares$515 Million0.4% of portfolio
-
Flossbach Von Storch Ag Cologne, 2M4.36MShares$498 Million2.05% of portfolio
-
Black Rock Inc. New York, NY1.9MShares$216 Million0.0% of portfolio
-
Temasek Holdings (Private) LTD Singapore, U01.81MShares$206 Million0.88% of portfolio
About BioNTech SE
- Ticker BNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 242,684,992
- Market Cap $27.7B
- Description
- BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...